MAFLD in Obese Children: A Challenging Definition

MAFLD in Obese Children: A Challenging Definition

Background: Recently, the new definition of Metabolic (dysfunction) associated fatty liver disease (MAFLD) has gained remarkable scientific interest. We aimed to evaluate the effectiveness of MAFLD definition in selecting obese children at higher cardiovascular risk. Methods: A total of 954 obese ch...

Full description

Bibliographic Details
Main Authors:	Anna Di Sessa, Stefano Guarino, Giuseppina Rosaria Umano, Mattia Arenella, Salvatore Alfiero, Gaetano Quaranta, Emanuele Miraglia del Giudice, Pierluigi Marzuillo
Format:	Article
Language:	English
Published:	MDPI AG 2021-03-01
Series:	Children
Subjects:	fatty liver metabolic dysfunction children obesity
Online Access:	https://www.mdpi.com/2227-9067/8/3/247

Similar Items

The Impact of COVID-19 Pandemic Lockdown on the Relationship between Pediatric MAFLD and Renal Function
by: Maria Sole Valentino, et al.
Published: (2023-03-01)

<i>LSS</i> rs2254524 Increases the Risk of Hypertension in Children and Adolescents with Obesity
by: Giuseppina Rosaria Umano, et al.
Published: (2023-08-01)

Association between Hepatic Steatosis and Obstructive Sleep Apnea in Children and Adolescents with Obesity
by: Marco Carotenuto, et al.
Published: (2021-11-01)

Renal Involvement in Children with Type 2 Diabetes Mellitus Onset: A Pilot Study
by: Pierluigi Marzuillo, et al.
Published: (2021-07-01)

Pediatric Sleep Questionnaire Predicts Moderate-to-Severe Obstructive Sleep Apnea in Children and Adolescents with Obesity
by: Giuseppina Rosaria Umano, et al.
Published: (2022-08-01)

Metabolic Dysfunction–Associated Fatty Liver Disease (MAFLD) and Thyroid Function in Childhood Obesity: A Vicious Circle?
by: Valeria Calcaterra, et al.
Published: (2024-02-01)

Therapeutics for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
by: Kamlesh K. Bhopale, et al.
Published: (2023-10-01)

Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases
by: Jorge Gutiérrez-Cuevas, et al.
Published: (2021-10-01)

Development and validation of a new nomogram to screen for MAFLD
by: Haoxuan Zou, et al.
Published: (2022-12-01)

A comparison of NAFLD and MAFLD diagnostic criteria in contemporary urban healthy adults in China: a cross-sectional study
by: Qiling Liu, et al.
Published: (2022-11-01)

From Clinical Scenarios to the Management of Lower Urinary Tract Symptoms in Children: A Focus for the General Pediatrician
by: Pier Luigi Palma, et al.
Published: (2023-04-01)

Correlation between serum uric acid and body fat distribution in patients with MAFLD
by: Min Tao, et al.
Published: (2023-09-01)

Increased Serum Adipsin Correlates with MAFLD and Metabolic Risk Abnormalities
by: Pan J, et al.
Published: (2023-01-01)

Circulating levels of DLK1 and glucose homeostasis in girls with obesity: A pilot study
by: Stefania Palumbo, et al.
Published: (2022-12-01)

Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease
by: Alessandra Musio, et al.
Published: (2023-04-01)

Diagnostic Clues in Pediatric Nutcracker Syndrome: From Two Clinical Cases to Current Literature Analysis
by: Speranza Cioffi, et al.
Published: (2022-12-01)

MAFLD and Celiac Disease in Children
by: Serena Scapaticci, et al.
Published: (2023-01-01)

Impact and usefulness of the transition to the new MAFLD classification for non-B, non-C HCC: a retrospective cohort study
by: Yusuke Johira, et al.
Published: (2023-06-01)

The association between endocrine disrupting chemicals and MAFLD: Evidence from NHANES survey
by: Ruoyi Lei, et al.
Published: (2023-05-01)

The Role of the GH/IGF1 Axis on the Development of MAFLD in Pediatric Patients with Obesity
by: Antonella Mosca, et al.
Published: (2022-12-01)

Comparison of MAFLD and NAFLD Characteristics in Children
by: Yunfei Xing, et al.
Published: (2023-03-01)

Thwarting Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) with Common Bean: Dose- and Sex-Dependent Protection against Hepatic Steatosis
by: Tymofiy Lutsiv, et al.
Published: (2023-01-01)

Effects of Dietary Nutrients on Fatty Liver Disease Associated With Metabolic Dysfunction (MAFLD): Based on the Intestinal-Hepatic Axis
by: Nan Yao, et al.
Published: (2022-06-01)

Chronic jet lag alters gut microbiome and mycobiome and promotes the progression of MAFLD in HFHFD-fed mice
by: Ruoyi Zheng, et al.
Published: (2023-12-01)

Long-term exposure to ambient PM2.5 and its constituents is associated with MAFLD
by: Bing Guo, et al.
Published: (2023-12-01)

MAFLD and CKD: An Updated Narrative Review
by: Alessandro Mantovani, et al.
Published: (2022-06-01)

The Transition of Cardiovascular Disease Risks from NAFLD to MAFLD
by: Zifeng Yang, et al.
Published: (2023-05-01)

New Insights from Metabolomics in Pediatric Renal Diseases
by: Simona Riccio, et al.
Published: (2022-01-01)

Acute Kidney Injury in Children with Acute Appendicitis
by: Pierluigi Marzuillo, et al.
Published: (2022-04-01)

Diagnostic Performance of Height-Estimated Baseline Creatinine in Diagnosing Acute Kidney Injury in Children with Type 1 Diabetes Mellitus Onset
by: Stefano Guarino, et al.
Published: (2022-06-01)

A systematic review and meta-analysis of cohort studies on the potential association between NAFLD/MAFLD and risk of incident atrial fibrillation
by: Ben‐Gang Zhou, et al.
Published: (2023-07-01)

Early Renal Ultrasound in Patients with Congenital Solitary Kidney Can Guide Follow-Up Strategy Reducing Costs While Keeping Long-Term Prognostic Information
by: Stefano Guarino, et al.
Published: (2022-02-01)

Using new indices to predict metabolism dysfunction-associated fatty liver disease (MAFLD): analysis of the national health and nutrition examination survey database
by: Xu Ming Li, et al.
Published: (2024-03-01)

The NAFLD–MAFLD debate through the lens of the Arab world
by: Mina Tharwat, et al.
Published: (2022-01-01)

Prediction of MAFLD and NAFLD using different screening indexes: A cross-sectional study in U.S. adults
by: Hongye Peng, et al.
Published: (2023-01-01)

COVID-19 and MAFLD/NAFLD: An updated review
by: Ali Nowroozi, et al.
Published: (2023-03-01)

Editorial: The NAFLD-MAFLD conundrum
by: Andrea Dalbeni, et al.
Published: (2023-09-01)

Telemedicine as an Option for Monitoring Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Patients Facing the COVID-19 Pandemic: A Systematic Review and Meta-Analysis
by: Femmy Nurul Akbar, et al.
Published: (2024-03-01)

Non-Obese MAFLD Is Associated with Colorectal Adenoma in Health Check Examinees: A Multicenter Retrospective Study
by: Shuhei Fukunaga, et al.
Published: (2021-05-01)

Is Metabolic Syndrome Useful for Identifying Youths with Obesity at Risk for NAFLD?
by: Procolo Di Bonito, et al.
Published: (2023-01-01)